Market revenue in 2023 | USD 225.5 million |
Market revenue in 2030 | USD 588.9 million |
Growth rate | 14.7% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.18% in 2023. Horizon Databook has segmented the Spain dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of chronic & infectious diseases and continuous public–private initiatives to increase awareness about innovative NGS solutions are anticipated to be major factors propelling the demand for NGS in Spain.
The meetings aimed to address sequencing challenges faced by bioinformatics researchers and biologists by updating them about the latest NGS platforms. Spain has become an attractive and competitive market for NGS.
This investment aims to enhance the capacity of the regional health system and use scientific knowledge as a tool to embrace economic competitiveness by contributing to innovation. The segments of investment include genomic medicine, big data health, predictive medicine, advanced & personalized therapy, and precision medicine training.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Spain dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account